Finance entity

Nebius

Company NBIS

Of the tracked stories, 1 of 2 also mention Bitcoin, the most common co-covered peer. Across a 145-day span, the pace is roughly 0.1 stories per week. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.

Last mentioned: Jul 27, 2026

Entity pulse

Recent coverage · Nebius

2 stories
5.5 avg impact
50% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.

  • 50% positive
  • 50% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Nebius

Of the tracked stories, 1 of 2 also mention Bitcoin, the most common co-covered peer. Across a 145-day span, the pace is roughly 0.1 stories per week. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. earnings accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The 5.5 average consequence score is below the beat benchmark of 6.4 in the same window. Nebius appears in 2 tracked Finance stories published from March 4, 2026 through July 26, 2026.

Stories tracked
2
Per week
0.1
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 2843 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Nebius. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Nebius 2

Markets Bullish

Growth Stock Outlook 2026: Pharma Giants and AI Disruptors Lead Market

As equity markets navigate 2026 volatility, analysts are highlighting a mix of established healthcare leaders and emerging AI infrastructure plays as top growth opportunities. Eli Lilly’s dominance in the obesity market and Nebius’s projected $7 billion revenue surge represent the diverse strategies for capturing alpha in the current cycle.

2 sources

Nebius is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.